Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 2,519 sh | Sep 18, 2026 |
| 5 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,465 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Fitzpatrick JenniferCLO and Head of Program Mgmt. |  SIONSionna Therapeutics, Inc.Grant or award | A | — 103.1K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Tax withholding | F | $24K 341 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Aufderhaar DavidChief Financial Officer |  SFIXStitch Fix, Inc.Option exercise | M | — 43.9K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 687 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 567 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Option exercise | M | — 400 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | $12K 400 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | — 900 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 885 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 885 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Ganesan SatishSee Remarks |  SYNASYNAPTICS IncTax withholding | F | $13K 147 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Hanson KristopherGeneral Counsel |  MPLTMapLight Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $193K 16.5K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Derivative conversion | C | $56K 600 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Kleiser Kirk E.Director |  CLSTCatalyst Bancorp, Inc.Option exercise | M | $6,390 529 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Tax withholding | F | $31K 439 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Mettler JodyChief Operating Officer |  BTGOBITGO HOLDINGS, INC.Grant or award | A | — 200.0K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 2,472 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Tax withholding | F | $23K 331 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,888 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner |  DUOLDuolingo, Inc.Derivative conversion · 10b5-1 plan | C | $332K 23.0K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Tax withholding | F | $17K 245 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Krishnamurthy Balaji (A)Chief Financial Officer | UBERUber Technologies, Inc Option exercise | M | — 490 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | $12K 400 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Fitzpatrick JenniferCLO and Head of Program Mgmt. | SIONSionna Therapeutics, Inc. Disposition to issuer | D | — 103.1K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Tax withholding | F | $45K 634 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Flees Lori AnnDirector, President & CEO |  VVVVALVOLINE INCGrant or award | A | $974 36 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,465 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Kleiser Kirk E.Director | CLSTCatalyst Bancorp, Inc. Option exercise | M | — 16.9K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | — 900 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Hazelbaker JillSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 352 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 1,133 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Option exercise | M | — 4,042 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 5 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Derivative conversion | C | $121K 1,332 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 5 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Derivative conversion | C | $123K 4,035 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 4 | Offer OrChief Executive Officer |  SMWBSIMILARWEB LTD.Open-market sale · 10b5-1 plan | SELL | $254K 30.4K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 4 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $225K 7,869 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 4 | Offer OrChief Executive Officer | SMWBSIMILARWEB LTD. Open-market sale · 10b5-1 plan | SELL | $384K 45.7K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 3 | Colis Peter GeorgeDirector, CEO and Secretary |  LIFEEthos Technologies Inc.Open-market sale · 10b5-1 plan | SELL | $12K 315 sh | Sep 18, 2026 traded Sep 17, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K